CJC-1295

Also known as: Modified GRF 1-29, DAC:GRF

Overview

Growth hormone optimization and anti-aging

CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) that stimulates the pituitary gland to release growth hormone. It exists in two forms: with DAC (Drug Affinity Complex) for extended half-life, or without DAC for shorter duration. The peptide is popular in anti-aging and bodybuilding communities for its ability to increase GH levels, potentially improving body composition, recovery, and sleep quality.

Mechanism of Action

Growth hormone releasing hormone (GHRH) analog that stimulates pituitary gland to produce more growth hormone

Dosage Information

Parameter	Detail
Administration	Subcutaneous injection
Typical Dose	1-2mg twice weekly (with DAC)
Frequency	Twice weekly

Side Effects

Reported adverse effects from clinical data and post-market surveillance

Common Side Effects

Injection site reactions

Water retention

Numbness or tingling

Increased hunger

Serious Side Effects

Potential pituitary tumor growth

Insulin resistance

Carpal tunnel syndrome

!Contraindications

Do not use this peptide if any of the following apply

Active cancer
Pituitary tumors
Pregnancy
Children

Clinical Evidence

Evidence Quality

Emerging

Clinical Trial Phase

Preclinical / Not submitted

View Key Study

Cost Comparison

Estimated monthly costs compared to similar peptides

Peptide	Monthly Cost	FDA Status
CJC-1295	$35 - $70/mo	Not submitted
MK-677	$50 - $100/mo	Phase 2
Ipamorelin	$35 - $70/mo	Not submitted
GHRP-6	$35 - $70/mo	Not submitted
Sermorelin	$150 - $350/mo	FDA Approved

Compare CJC-1295

See how CJC-1295 stacks up against similar peptides

CJC-1295 vs Ipamorelin

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy or medication. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary.